Consegna Pharma Receives NIH Research Grant to Develop CP216, a Sustained-Release Naloxone Treatment for Opioid Overdose Reversal

Long-acting naloxone can potentially help to prevent renarcotization. PITTSBURGH (PRWEB) DECEMBER 18, 2019 Consegna Pharma Inc. today announced a research grant awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), valued at approximately $218,000 for the continued development of CP216, the company’s[…]

Read more

HyperBorean Closes Angel Funding Round with Focus on Climate Change Solutions

HyperBorean, a heating, ventilation and air conditioning (HVAC) startup receives angel funding for top climate change drawdown solution. WICHITA, KAN. (PRWEB) DECEMBER 18, 2019 HyperBorean closed its pre-seed angel round of financing totaling $2,100,000. Angel investors included members of Landmark Angels and Precocity Capital, both in Connecticut, and a principal with Heartland P5 in[…]

Read more

G-CON Manufacturing Announces Major Expansion that Increases its Superstructure Manufacturing Capacity

25,000 sq. ft. expansion doubles G-CON’s superstructure production while maintaining all production in-house. COLLEGE STATION, TEXAS (PRWEB) DECEMBER 18, 2019 G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions, today announced the expansion of its manufacturing facility for POD superstructures in College Station, TX. Previously limited to manufacturing only 50 superstructures[…]

Read more

Society for Immunotherapy of Cancer to Host Unique 2-Day Workshop Focused on Interrogating the Tumor-Specific Surfaceome for Immune Targeting

The Society for Immunotherapy of Cancer (SITC) will host an innovative workshop on April 23–24, 2020, in San Diego, which will focus on the identification and biology of cancer cell surface molecules, and implications for cancer immunotherapy drug delivery and targeting. MILWAUKEE (PRWEB) DECEMBER 18, 2019 The Society for Immunotherapy of[…]

Read more

Rev1 Ventures Launches $15MM Fund with The Ohio State University and Nationwide Children’s Hospital to Support Research-based Healthcare Innovation

Investor Startup Studio Triples Down on Infrastructure to Support Life Sciences Spinouts COLUMBUS, OHIO (PRWEB) DECEMBER 17, 2019 Today, Rev1 Ventures, the investor startup studio that combines capital and strategic services to help startups scale and corporations innovate, is announcing the launch of its second fund focused on life sciences companies. The $15MM[…]

Read more